
Miller Pharmaceutical Private Limited
About Miller Pharmaceutical Private Limited
Data last updated:
Miller Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 March 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2022PTC160606.
The company has an authorised share capital of ₹24 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Chaitanya Pavuluri and Alan Joel Miller.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at P No.39 Hi – Tech City Phase – II Madhapur Serilingampally, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.44 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹7.89 Lakh (net margin -48%) and EBITDA of -₹7.87 Lakh (EBITDA margin -47.8%).
Company details
Contact details
Miller Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressP No.39 Hi – Tech City Phase – II Madhapur Serilingampally, Hyderabad, Telangana, India – 500081
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Miller Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Miller Pharmaceutical Private Limited, buy the company report.
Financials of Miller Pharmaceutical Private Limited
FY 2024 filings availableMiller Pharmaceutical Private Limited reported revenue of ₹16.44 Lakh (down 85% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 85% in the latest year. EBITDA fell 164% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹7.87 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹7.89 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -47.8% | ||
| Net Profit Margin | -48% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Miller Pharmaceutical Private Limited, buy the company report.
Board of directors of Miller Pharmaceutical Private Limited
Miller Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chaitanya Pavuluri | Director | 15 Mar 2022 | 4 Years 7 Months | Current |
| Badanidiyoor Laxmeesha Bhat Aravinda | Additional Director | 15 Dec 2022 | 3 Years 10 Months | Current |
| Alan Joel Miller | Director | 15 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Miller Pharmaceutical Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mirdha Real Estate Private Limited | ₹16.44 Lakh (FY 2024) | Purulia, West Bengal, India | ||||
| Jinideep Electronics Private Limited | ₹16.44 Lakh (FY 2022) | 327.0% | New Delhi, Delhi, India | |||
| Al Am Tech Communication Private Limited | ₹16.44 Lakh (FY 2021) | 11.0% | Kolkata, West Bengal, India | |||
| Ishwar Commercial Private Limited | ₹16.44 Lakh (FY 2019) | 76.0% | Kolkata, West Bengal, India | |||
| Miller Pharmaceutical Private Limitedthis company | ₹16.44 Lakh (FY 2024) | -₹7.89 Lakh | -48% | -85.0% | Hyderabad, Telangana, India | |
| Prinsha Healthcare Private Limited | ₹16.44 Lakh (FY 2023) | 62.0% | Ranchi, Jharkhand, India | |||
| Helax Probic Private Limited | ₹16.44 Lakh (FY 2024) | 141.0% | Delhi, India | |||
| Tricept Pharmaceuticals Private Limited | ₹16.44 Lakh (FY 2022) | -97.0% | Chennai, Tamil Nadu, India | |||
| Colisc Biotech Private Limited | ₹16.43 Lakh (FY 2019) | Pune, Maharashtra, India | ||||
| Manandi Pharmaceuticals Private Limited | ₹16.43 Lakh (FY 2025) | -32.0% | Muzaffarpur, Bihar, India |
To see the full peer comparison of Miller Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Miller Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Miller Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Miller Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Miller Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Badanidiyoor Laxmeesha Bhat Aravinda was appointed as Additional Director on 15 Dec 2022.
Frequently asked questions
Miller Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 March 2022 (4+ years old) and is registered under CIN U51909TG2022PTC160606.
Miller Pharmaceutical has 3 current directors:
- Chaitanya Pavuluri - Director
- Badanidiyoor Laxmeesha Bhat Aravinda - Additional Director
- Alan Joel Miller - Director
The latest financial statements of Miller Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Miller Pharmaceutical is U51909TG2022PTC160606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Miller Pharmaceutical was incorporated on 15 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Miller Pharmaceutical by revenue are Mirdha Real Estate Private Limited, Jinideep Electronics Private Limited, Al Am Tech Communication Private Limited, Ishwar Commercial Private Limited, Prinsha Healthcare Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Badanidiyoor Laxmeesha Bhat Aravinda was appointed as Additional Director on 15 Dec 2022. Alan Joel Miller was appointed as Director on 15 Mar 2022. Chaitanya Pavuluri was appointed as Director on 15 Mar 2022.
The registered office of Miller Pharmaceutical is at P No.39 Hi – Tech City Phase – II Madhapur Serilingampally, Hyderabad, Telangana, India – 500081.
Miller Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Miller Pharmaceutical can be reached at its registered office: P No.39 Hi – Tech City Phase – II Madhapur Serilingampally, Hyderabad, Telangana, India – 500081.
Miller Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

